agilon health, inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $5.9B | $6.1B | $4.3B | $2.4B | $1.5B |
| Operating expenses | — | — | — | $2.8B | $2.2B |
| Operating income | -$463.2M | -$292.1M | -$232.1M | -$105.4M | -$372.2M |
| Interest expense | $6.6M | $6.2M | $6.7M | $4.5M | $6.1M |
| Pretax income | -$404.1M | -$248.8M | -$194.5M | -$90.7M | -$383.0M |
| Income tax expense | $1.3M | $1.5M | $791,000 | $1.6M | $886,000 |
| Net income | -$391.3M | -$260.2M | -$262.6M | -$106.6M | -$406.5M |
| Balance Sheet | |||||
| Cash and equivalents | $173.7M | $188.2M | $107.6M | $465.3M | $1.0B |
| Current assets | $1.1B | $1.5B | $1.5B | $1.5B | $1.4B |
| Total assets | $1.3B | $1.7B | $1.7B | $1.7B | $1.6B |
| Current liabilities | $1.1B | $1.2B | $977.2M | $535.1M | $357.0M |
| Total liabilities | $1.1B | $1.3B | $1.1B | $656.9M | $494.7M |
| Total debt | $35.0M | — | $38.8M | — | — |
| Stockholders' equity | $126.7M | $471.0M | $661.8M | $1.0B | $1.1B |
| Cash Flow Statement | |||||
| Cash from operations | -$105.8M | -$57.8M | -$156.2M | -$130.8M | -$148.2M |
| Depreciation and amortization | $28.6M | $24.5M | $20.2M | $13.8M | $14.7M |
| Stock-based compensation | $49.1M | $50.7M | $69.5M | $28.4M | $292.4M |
| Capital expenditure | $13.2M | $13.3M | $15.8M | $15.4M | $6.6M |
| Free cash flow | -$119.0M | -$71.0M | -$172.0M | -$146.2M | -$154.7M |
| Share repurchases | $0 | $0 | $200.0M | $0 | $0 |
| Impairments | $36.1M | $3.6M | $0 | $0 | — |
Shares outstanding 16.7M · Free float 97.5%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.